Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriem Boufraqech

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Nucleic Acids Research|October 9, 2015
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samplesSudheer Kumar Gara, Yonghong Wang, Dhaval Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2019
Histone H2AX promotes neuronal health by controlling mitochondrial homeostasisUrbain Weyemi, Bindu D Paul, Deeya Bhattacharya, et al.
Oncotarget|September 26, 2018
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of responseNaris Nilubol, Myriem Boufraqech, Lisa Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Dual Targeting of <i>BRAF <sup>V600E</sup></i> and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative StressJiangnan Hu, Chandrayee Ghosh, Tejinder P Khaket, et al.
Surgery|December 3, 2014
Hyperparathyroidism-jaw tumor syndrome: Results of operative managementAmit Mehta, Dhaval Patel, Avi Rosenberg, et al.
Cancer|November 18, 2017
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotypeXavier M Keutgen, Suresh Kumar, Sudheer Kumar Gara, et al.
Plos One|July 23, 2014
ZNF367 inhibits cancer progression and is targeted by miR-195Meenu Jain, Lisa Zhang, Myriem Boufraqech, et al.
International Journal of Endocrine Oncology|August 17, 2018
68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumorJasmine Shell, Xavier M Keutgen, Corina Millo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)Chandrayee Ghosh, Suresh Kumar, Yevgeniya Kushchayeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid CancerAmit Mehta, Lisa Zhang, Myriem Boufraqech, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Nucleic Acids Research|October 9, 2015
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samplesSudheer Kumar Gara, Yonghong Wang, Dhaval Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2019
Histone H2AX promotes neuronal health by controlling mitochondrial homeostasisUrbain Weyemi, Bindu D Paul, Deeya Bhattacharya, et al.
Oncotarget|September 26, 2018
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of responseNaris Nilubol, Myriem Boufraqech, Lisa Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Dual Targeting of <i>BRAF <sup>V600E</sup></i> and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative StressJiangnan Hu, Chandrayee Ghosh, Tejinder P Khaket, et al.
Surgery|December 3, 2014
Hyperparathyroidism-jaw tumor syndrome: Results of operative managementAmit Mehta, Dhaval Patel, Avi Rosenberg, et al.
Cancer|November 18, 2017
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotypeXavier M Keutgen, Suresh Kumar, Sudheer Kumar Gara, et al.
Plos One|July 23, 2014
ZNF367 inhibits cancer progression and is targeted by miR-195Meenu Jain, Lisa Zhang, Myriem Boufraqech, et al.
International Journal of Endocrine Oncology|August 17, 2018
68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumorJasmine Shell, Xavier M Keutgen, Corina Millo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Combinatorial Strategy for Targeting <i>BRAF</i> <sup>V600E</sup>-Mutant Cancers with BRAF<sup>V600E</sup> Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)Chandrayee Ghosh, Suresh Kumar, Yevgeniya Kushchayeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid CancerAmit Mehta, Lisa Zhang, Myriem Boufraqech, et al.
Pageof 5